On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy

Recently, considerable interest has emerged in the development of biosensors to detect biomarkers and immune checkpoints to identify and measure cancer through liquid biopsies. The detection of cancer biomarkers from a small volume of blood is relatively fast compared to the gold standard of tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Mummareddy, Sai, Pradhan, Stuti, Narasimhan, Ashwin Kumar, Natarajan, Arutselvan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699359/
https://www.ncbi.nlm.nih.gov/pubmed/34940257
http://dx.doi.org/10.3390/bios11120500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699359/
https://www.ncbi.nlm.nih.gov/pubmed/34940257
http://dx.doi.org/10.3390/bios11120500

Ejemplares similares